Amplia Therapeutics Ltd.ASX: ATX

FDA Fast Track Designation for Narmafotinib

Sep 20, 2024 at 3:00 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment